ALS biotech QurAlis gets $88M boost from 4 pharmas for pair of PhI ... - Endpoints News
Q&A with Christine Baeder, new chair of the generic industry's AAM - Endpoints News
February 2023 Recap: Drug Pipeline Updates - MPR - Monthly Prescribing Reference
Sage Therapeutics, Inc. (NASDAQ:SAGE) Given Consensus ... - MarketBeat
Health Care Down as Risk Aversion Weighs on Biotech -- Health Care Roundup - Marketscreener.com
Health Care Down as Risk Aversion Weighs on Biotech -- Health Care Roundup - MarketWatch
FDA raises questions in adcomm briefing docs for Roche's Polivy ... - Endpoints News
An eye, 15 seconds and striking animation: How Horizon's thyroid ... - Endpoints News
Mesoblast's aGVHD cell therapy will get another shot at the FDA - Endpoints News
Net at Work Acquires Innovation ERP, a Leading Sage X3 and Sage 300 Business Consulting Firm - Benzinga

Pages